|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1995-3-6
|
|
pubmed:abstractText |
To investigate the efficacy of combined hyperfractionated radiation therapy (HFX RT) and concurrent chemotherapy (CHT) in stage IIIA or IIIB non-small-cell lung cancer (NSCLC) compared with that of HFX RT alone.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
452-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7844608-Adult,
pubmed-meshheading:7844608-Aged,
pubmed-meshheading:7844608-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:7844608-Carboplatin,
pubmed-meshheading:7844608-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:7844608-Combined Modality Therapy,
pubmed-meshheading:7844608-Drug Administration Schedule,
pubmed-meshheading:7844608-Etoposide,
pubmed-meshheading:7844608-Female,
pubmed-meshheading:7844608-Humans,
pubmed-meshheading:7844608-Lung Neoplasms,
pubmed-meshheading:7844608-Male,
pubmed-meshheading:7844608-Middle Aged,
pubmed-meshheading:7844608-Neoplasm Metastasis,
pubmed-meshheading:7844608-Neoplasm Recurrence, Local,
pubmed-meshheading:7844608-Radiotherapy Dosage,
pubmed-meshheading:7844608-Survival Rate,
pubmed-meshheading:7844608-Time Factors
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer.
|
|
pubmed:affiliation |
Department of Oncology, University Hospital, Kragujevac, Yugoslavia.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
